Galena Biopharma Inc (NASDAQ:GALE)

1.45
Delayed Data
As of Apr 24
 +0.02 / +1.40%
Today’s Change
1.30
Today|||52-Week Range
3.58
-3.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.002.5M9.3M
 
 
 
Cost of Goods Sold0.000.00199.0K954.0K
 
 
 
Depreciation And Amortization163.0K49.0K452.0K889.0K
 
 
 
 
 
 
Operating ExpensesGross Income-163.0K-49.0K1.8M7.5M
 
 
 
 
 
General Expenses20.6M21.2M35.7M57.7M
 
 
 
 
 
Research And Development11.5M14.6M21.1M28.4M
 
 
 
 
 
Total Operating Expenses20.8M21.2M36.3M59.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.8M-21.2M-33.8M-50.2M
 
 
 
 
 
Extraordinary Credit10.0M0.00--16.7M
 
 
 
Extraordinary Charge-900.0K-13.1M-44.9M-2.0M
 
 
 
 
 
Interest Expense On Debt--33.0K807.0K1.1M
 
 
 
 
Other Expenses177.0K0.003.9M0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.5M-34.4M-75.6M-36.6M
 
 
 
 
 
Income Taxes0.00-1.1M-1.1M0.00
 
 
 
Discontinued Operations0.00-1.6M0.000.00
 
 
Net Income-11.5M-35.0M-76.7M-36.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.3M62.5M90.2M119.4M
 
 
 
 
 
Shares To Calculate EPS Diluted36.3M62.5M90.2M119.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.32-$0.56-$0.85-$0.31
 
 
 
 
 
EPS Diluted-$0.32-$0.56-$0.85-$0.31
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account